We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MP:NYSEMP Materials Corp. Analysis

Data as of 2026-05-21 - not real-time

$56.50

Latest Price

8/10Risk

Risk Level: High

Executive Summary

MP Materials is currently trading below its short‑term moving averages, with the price sitting under both the twenty‑day and fifty‑day simple averages, indicating a modest downside bias. The relative strength index sits in the mid‑range, suggesting neither overbought nor oversold conditions, while the MACD shows a bearish divergence that reinforces short‑term pressure. Volatility is elevated and the stock’s beta is well above market, reflecting heightened price swings and sensitivity to broader market moves. Valuation metrics are stretched, with forward earnings multiples and price‑to‑sales ratios at the high end of the sector spectrum, pointing to an overvalued pricing profile at present.
On the fundamental side, the company reported a strong earnings beat, driven by record rare‑earth oxide production and a sizable jump in revenue year‑over‑year. Despite the top‑line momentum, profitability remains negative, cash flow is strained and leverage is elevated, which tempers the optimism from the growth narrative. Analysts have issued a strong‑buy consensus, betting on the strategic importance of domestic rare‑earth supply for emerging technologies such as artificial intelligence and data centers. The combination of solid operational progress, strategic positioning and a supportive analyst outlook creates a compelling medium‑ to long‑term thesis, even as short‑term technical signals and valuation concerns suggest caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • recent earnings beat but bearish MACD
  • price below key moving averages
  • elevated volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • record rare‑earth oxide output
  • strong revenue growth trajectory
  • strategic domestic supply positioning

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • critical role in AI and data‑center supply chains
  • planned capacity expansion and capex investment
  • limited competitive landscape in U.S. rare‑earths

Key Metrics & Analysis

Financial Health

Revenue Growth118.60%
Profit Margin-20.48%
P/E Ratio48.5
ROE-4.17%
ROA-2.10%
Debt/Equity44.02
P/B Ratio5.1
Op. Cash Flow$-94466000
Free Cash Flow$-174843504

Technical Analysis

TrendNeutral
RSI41.2
Support$53.58
Resistance$76.80
MA 20$63.73
MA 50$59.04
MA 200$63.11
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29

Valuation

Target Price$81.21
Upside/Downside43.74%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.54
Volatility71.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.